Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yasmine Nivoix"'
Autor:
Mauricette Michallet, Jean-Pierre Gangneux, Gilbert Deray, Jean-Paul Mira, Raoul Herbrecht, Jean-François Timsit, Arnaud Pigneux, Yasmine Nivoix, Serge Alfandari, Patricia Ribaud, Mohamad Sobh, Ibrahim Yakoub-Agha, Dominique Larrey
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:35-45
We have presented a practical guide developed by a working group of experts in infectious diseases and hematology to summarize the different recommendations issued by the different international groups on antifungal agents used for hematology patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f25615b69fdd5e6dd6ff84fd2f3ce677
https://doi.org/10.1016/j.clml.2020.08.010
https://doi.org/10.1016/j.clml.2020.08.010
Autor:
Bénédicte Gourieux, Bruno Michel, Fanny Reisz, Thierry Nai, Aurélie Reiter-Schatz, Marion Fourtage, Yasmine Nivoix, Yvon Ruch, François Danion, Julia Walther, Anne Sophie Belmas
Publikováno v:
European Journal of Hospital Pharmacy
Objective The aims of this study were to describe prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis (primary endpoint), then to characterise pharmaceutical interventions (PIs) target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f13c6bee3eb27d942d30a3ee336f50
https://doi.org/10.1136/ejhpharm-2020-002449
https://doi.org/10.1136/ejhpharm-2020-002449
Publikováno v:
Seminars in respiratory and critical care medicine. 41(1)
Invasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ transplantation, inherited or acquired immunodeficiency, administration of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3b1141cd1b907bceb59d1513fe406e
https://pubmed.ncbi.nlm.nih.gov/32000286
https://pubmed.ncbi.nlm.nih.gov/32000286
Publikováno v:
Seminars in respiratory and critical care medicine. 41(1)
Invasive fungal diseases primarily occur in immunocompromised patients. Immunosuppression has become more prevalent due to novel treatments, and this has led to a rise in the incidence of invasive fungal diseases. The antifungal armamentarium has lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2cd68062fb77ef72d93b154a01eb6c8
https://pubmed.ncbi.nlm.nih.gov/32000291
https://pubmed.ncbi.nlm.nih.gov/32000291
Autor:
Yasmine Nivoix, Bénédicte Gourieux, Julia Walther, Christian Debry, Nicolas Simon, Doris Vigouroux
Publikováno v:
Nutrition Clinique et Métabolisme. 32:113-121
Resume Objectif Evaluer les pratiques de prescription et d’administration des medicaments par sonde de nutrition enterale et ameliorer les informations transmises au patient au retour a domicile. Materiel et methodes Une evaluation des pratiques de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::783d5f2e79d7d96b8c01bb3b1f2a47d1
https://doi.org/10.1016/j.nupar.2017.12.002
https://doi.org/10.1016/j.nupar.2017.12.002
Publikováno v:
Journal de Mycologie Médicale. 28:8-14
Triazoles compounds are first-line agents for the treatment of invasive fungal diseases. Isavuconazole is the most recent triazole compound, approved in 2015 by the FDA and the EMA to treat invasive aspergillosis and mucormycosis. We reviewed here th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c903c7c4eb9b6da4d5820829e018ad29
https://doi.org/10.1016/j.mycmed.2018.02.005
https://doi.org/10.1016/j.mycmed.2018.02.005
Publikováno v:
Medical mycology. 44(Supplement_1)
Despite recent improvements in outcome of invasive aspergillosis there are still high failure and fatality rates. The trial comparing voriconazole to amphotericin B deoxycholate has become a reference for clinical trials in invasive aspergillosis due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7bfa3d4f22d471d41cf6a62b537a35
https://pubmed.ncbi.nlm.nih.gov/30408917
https://pubmed.ncbi.nlm.nih.gov/30408917
Publikováno v:
Pharmacie Clinique et Thérapeutique
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21570ed3219fac9f29e656d0b8ad2996
https://doi.org/10.1016/b978-2-294-75077-9.00051-7
https://doi.org/10.1016/b978-2-294-75077-9.00051-7
Autor:
J. Gaudias, M. Clauzel-Montserrat, Bénédicte Gourieux, D. Vigouroux, A. Jarfaut, J.-F. Kempf, Yasmine Nivoix, P. Kehrli, Dominique Levêque
Publikováno v:
Annales Pharmaceutiques Françaises. 73:123-132
Resume Introduction Notre strategie actuelle de developpement des activites de pharmacie clinique integre une priorisation dans les services de chirurgie. Les patients de ces services sont typiquement des patients a risque : transferts, prescripteurs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cffd4bb717726fc2983f5e214ee345d4
https://doi.org/10.1016/j.pharma.2014.09.001
https://doi.org/10.1016/j.pharma.2014.09.001
Publikováno v:
Journal de mycologie medicale. 28(1)
Isavuconazole, the active moiety of its prodrug isavuconazonium, is a new extended-spectrum triazole whose activity against yeasts, molds, including Aspergillus and mucorales, and dimorphic fungi has been shown in vitro and in preclinical models. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a4ebf85ceb4cc71398498bc77011c7
https://pubmed.ncbi.nlm.nih.gov/29551442
https://pubmed.ncbi.nlm.nih.gov/29551442